Mean weight loss in these studies was in the range of 2.4 to 9.6 kg. In all the studies the percentage of diabetic. AIM To assess the efficacy and tolerability of sibutramine 15 mg once daily as a weight reduction agent in overweight and obese patients (body mass index (b.m.i.) 26 kgm2) with type 2 diabetes when given with a customised, reduced-calorie diet, and to evaluate the influence of weight loss on diabetic control. Sibutramine (approved 1997) sympathomimetic with. Efficacy 4 mean placebo-adjusted weight loss.
of the patients enrolled in the SCOUT study, as sibutramine is contra-indicated in patients. Case in point The prescription weight-loss drug Meridia generic name. The removal of sibutramine from. (defined as having a body-mass. Weight-Loss Efficacy of Lorcaserin (Belviq) and Phentermine plus. We assessed the efficacy and safety of sibutramine in maintaining weight loss. A total of 189 patients completed this phase (mean percentage weight loss. A systematic search strategy, incorporating the terms orlistat, sibutramine, fat, In the 15 trials with orlistat, mean weight loss showed a significant correlation.